Nivolumab–ipilimumab in renal cell carcinoma metastatic to the bones: A case report

In recent years, the introduction in the clinical setting of treatment combinations having immune checkpoint inhibitors as the backbone has dramatically improved the outcomes of patients suffering from advanced/metastatic renal cell carcinoma (RCC). Here we report the clinical course of a patient wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Di Napoli, Marilena, Pisano, Carmela, Setola, Sergio Venanzio, Perdonà, Sisto, Feroce, Florinda, Pignata, Sandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mattioli 1885 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10510992/
https://www.ncbi.nlm.nih.gov/pubmed/35765962
http://dx.doi.org/10.23750/abm.v93iS1.12876
_version_ 1785108059210645504
author Di Napoli, Marilena
Pisano, Carmela
Setola, Sergio Venanzio
Perdonà, Sisto
Feroce, Florinda
Pignata, Sandro
author_facet Di Napoli, Marilena
Pisano, Carmela
Setola, Sergio Venanzio
Perdonà, Sisto
Feroce, Florinda
Pignata, Sandro
author_sort Di Napoli, Marilena
collection PubMed
description In recent years, the introduction in the clinical setting of treatment combinations having immune checkpoint inhibitors as the backbone has dramatically improved the outcomes of patients suffering from advanced/metastatic renal cell carcinoma (RCC). Here we report the clinical course of a patient with a rapid and bulky bone recurrence of RCC after nephrectomy, experiencing a long-term benefit from the nivolumab–ipilimumab combination administered as first-line treatment. (www.actabiomedica.it)
format Online
Article
Text
id pubmed-10510992
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Mattioli 1885
record_format MEDLINE/PubMed
spelling pubmed-105109922023-09-21 Nivolumab–ipilimumab in renal cell carcinoma metastatic to the bones: A case report Di Napoli, Marilena Pisano, Carmela Setola, Sergio Venanzio Perdonà, Sisto Feroce, Florinda Pignata, Sandro Acta Biomed Case Report In recent years, the introduction in the clinical setting of treatment combinations having immune checkpoint inhibitors as the backbone has dramatically improved the outcomes of patients suffering from advanced/metastatic renal cell carcinoma (RCC). Here we report the clinical course of a patient with a rapid and bulky bone recurrence of RCC after nephrectomy, experiencing a long-term benefit from the nivolumab–ipilimumab combination administered as first-line treatment. (www.actabiomedica.it) Mattioli 1885 2022 2022-12-07 /pmc/articles/PMC10510992/ /pubmed/35765962 http://dx.doi.org/10.23750/abm.v93iS1.12876 Text en Copyright: © 2022 ACTA BIO MEDICA SOCIETY OF MEDICINE AND NATURAL SCIENCES OF PARMA https://creativecommons.org/licenses/by-nc-sa/4.0/This work is licensed under a Creative Commons Attribution 4.0 International License
spellingShingle Case Report
Di Napoli, Marilena
Pisano, Carmela
Setola, Sergio Venanzio
Perdonà, Sisto
Feroce, Florinda
Pignata, Sandro
Nivolumab–ipilimumab in renal cell carcinoma metastatic to the bones: A case report
title Nivolumab–ipilimumab in renal cell carcinoma metastatic to the bones: A case report
title_full Nivolumab–ipilimumab in renal cell carcinoma metastatic to the bones: A case report
title_fullStr Nivolumab–ipilimumab in renal cell carcinoma metastatic to the bones: A case report
title_full_unstemmed Nivolumab–ipilimumab in renal cell carcinoma metastatic to the bones: A case report
title_short Nivolumab–ipilimumab in renal cell carcinoma metastatic to the bones: A case report
title_sort nivolumab–ipilimumab in renal cell carcinoma metastatic to the bones: a case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10510992/
https://www.ncbi.nlm.nih.gov/pubmed/35765962
http://dx.doi.org/10.23750/abm.v93iS1.12876
work_keys_str_mv AT dinapolimarilena nivolumabipilimumabinrenalcellcarcinomametastatictothebonesacasereport
AT pisanocarmela nivolumabipilimumabinrenalcellcarcinomametastatictothebonesacasereport
AT setolasergiovenanzio nivolumabipilimumabinrenalcellcarcinomametastatictothebonesacasereport
AT perdonasisto nivolumabipilimumabinrenalcellcarcinomametastatictothebonesacasereport
AT feroceflorinda nivolumabipilimumabinrenalcellcarcinomametastatictothebonesacasereport
AT pignatasandro nivolumabipilimumabinrenalcellcarcinomametastatictothebonesacasereport

Ejemplares similares